title: Rapid suppression of mitochondrial permeability transition by methylglyoxal. Role of reversible arginine modification.
abstract: Methylglyoxal (MG) (pyruvaldehyde) is a reactive carbonyl compound produced in glycolysis. MG can form covalent adducts on proteins resulting in advanced glycation end products that may alter protein function. Here we report that MG covalently modifies the mitochondrial permeability transition pore (PTP), a high conductance channel involved in the signal transduction of cell death processes. Incubation of isolated mitochondria with MG for a short period of time (5 min), followed by removal of excess free MG, prevented both ganglioside GD3- and Ca2+-induced PTP opening and the ensuing membrane depolarization, swelling, and cytochrome c release. Under these conditions MG did not significantly interfere with mitochondrial substrate transport, respiration, or oxidative phosphorylation. The suppression of permeability transition was reversible following extended incubation in MG-free medium. Of the 29 physiological carbonyl and dicarbonyl compounds tested only MG and its analogue glyoxal were able to specifically alter the behavior of the PTP. Using a set of arginine-containing peptides, we found that the major MG-derived arginine adduct formed, following a short time exposure to MG, was the 5-hydro-5-methylimidazol-4-one derivative. These findings demonstrate that MG rapidly modifies the PTP covalently and stabilizes the PTP in the closed conformation. This is probably due to the formation of an imidazolone adduct on an arginine residue involved in the control of PTP conformation (Linder, M. D., Morkunaite-Haimi, S., Kinnunen, P. J. K., Bernardi, P., and Eriksson, O. (2002) J. Biol. Chem. 277, 937-942). We deduce that the permeability transition constitutes a potentially important physiological target of MG.
authors.affiliation: Helsinki Biophysics and Biomembrane Group, Institute of Biomedicine/Biochemistry, P. O. Box 63, Haartmaninkatu 8, FIN-00014 University of Helsinki, Helsinki, Finland.
authors.forename: Oliver
authors.initials: O
authors.lastname: Speer
authors.forename: Sarune
authors.initials: S
authors.lastname: Morkunaite-Haimi
authors.forename: Julius
authors.initials: J
authors.lastname: Liobikas
authors.forename: Marina
authors.initials: M
authors.lastname: Franck
authors.forename: Linn
authors.initials: L
authors.lastname: Hensbo
authors.forename: Matts D
authors.initials: MD
authors.lastname: Linder
authors.forename: Paavo K J
authors.initials: PK
authors.lastname: Kinnunen
authors.forename: Theo
authors.initials: T
authors.lastname: Wallimann
authors.forename: Ove
authors.initials: O
authors.lastname: Eriksson
mesh_terms: D000818:Animals; D003574:Cytochrome c Group / Q000032:analysis; D007700:Kinetics; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000502:physiology*; D008933:Mitochondrial Swelling / Q000187:drug effects; D010539:Permeability; D011765:Pyruvaldehyde / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D003574:Cytochrome c Group; D011765:Pyruvaldehyde